Malaria vaccine hailed as a success

Malaria vaccine hailed as a success

Research published today (FRI) online in The Lancet Infectious Diseases indicates that the vaccine reduces the risk of infection by the parasite that causes severe malaria by 46 per cent over 15 months.

Malaria, which is passed to humans via infected mosquitoes, is one of the biggest killers of children in Africa.

Read more.